With FDA nod, AstraZeneca's FluMist becomes first self-administered flu vaccine

With FDA nod, AstraZeneca's FluMist becomes first self-administered flu vaccine

Source: 
Fierce Pharma
snippet: 

AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle.

The FDA has signed off on the British drugmaker’s influenza vaccine FluMist for self-administration by adults up to 49 years old and for administration by a parent or caregiver in kids between the ages of 2 and 17.